Literature DB >> 31362183

Oxytocin modulates alcohol-cue induced functional connectivity in the nucleus accumbens of social drinkers.

Patrick Bach1, Iris Reinhard2, Sina Bühler1, Sabine Vollstädt-Klein1, Falk Kiefer1, Anne Koopmann1.   

Abstract

The brain oxytocin system is involved in a wide range of addictive behaviors, inhibiting prime- and cue-induced relapse in preclinical models of substance use disorders. Especially the ability of oxytocin to modulate connectivity between the nucleus accumbens (NAc) and cortical regions has been identified as a factor likely to be critical to its effects on relapse. We thus investigated the effect of oxytocin on NAc functional connectivity during an alcohol cue-reactivity task. Thirteen male social drinkers participated in a randomized double-blind placebo-controlled cross-over functional magnetic resonance imaging (fMRI) alcohol cue-reactivity task with and without prior intranasal application of 24 IU oxytocin. Effects of oxytocin and functional connectivity during presentation of alcohol cues were assessed using ROI-to-ROI generalized psychophysiological interaction analyses. Oxytocin application significantly reduced NAc connectivity with the cuneus and thalamo-occipital connectivity, while enhancing connectivity between the paracingulate gyrus and precentral gyrus. This effect was specific to the alcohol presentation and was not found during processing of neutral pictures. In addition, the NAc-cuneus connectivity significantly correlated with alcohol cue-induced craving during the scanning session. For the first time, we could show that oxytocin selectively attenuates NAc connectivity during an alcohol cue-reactivity task which was related to changes in subjective craving for alcohol. This might reflect an attenuation of alcohol-cue saliency by oxytocin, which improves inhibitory control over craving and cue reactivity.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  alcohol addiction; alcohol craving; fMRI; functional connectivity; nucleus accumbens; oxytocin

Mesh:

Substances:

Year:  2019        PMID: 31362183     DOI: 10.1016/j.psyneuen.2019.104385

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  10 in total

Review 1.  FACTORS CONTRIBUTING TO THE ESCALATION OF ALCOHOL CONSUMPTION.

Authors:  Michael T Bowen; Olivier George; Dawn E Muskiewicz; F Scott Hall
Journal:  Neurosci Biobehav Rev       Date:  2021-11-25       Impact factor: 8.989

2.  Deep brain stimulation of the nucleus accumbens in the treatment of severe alcohol use disorder: a phase I pilot trial.

Authors:  Benjamin Davidson; Peter Giacobbe; Tony P George; Sean M Nestor; Jennifer S Rabin; Maged Goubran; Alexander J Nyman; Anusha Baskaran; Ying Meng; Christopher B Pople; Simon J Graham; Fred Tam; Clement Hamani; Nir Lipsman
Journal:  Mol Psychiatry       Date:  2022-07-21       Impact factor: 13.437

3.  Compensatory Hippocampal Recruitment Supports Preserved Episodic Memory in Autism Spectrum Disorder.

Authors:  Jeremy Hogeveen; Marie K Krug; Raphael M Geddert; J Daniel Ragland; Marjorie Solomon
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-09-05

Review 4.  Alcohol and oxytocin: Scrutinizing the relationship.

Authors:  Andrey E Ryabinin; Hannah D Fulenwider
Journal:  Neurosci Biobehav Rev       Date:  2021-06-05       Impact factor: 9.052

Review 5.  Oxytocin and vasopressin: Signalling, behavioural modulation and potential therapeutic effects.

Authors:  Mariana Rae; Mariana Lemos Duarte; Ivone Gomes; Rosana Camarini; Lakshmi A Devi
Journal:  Br J Pharmacol       Date:  2021-05-21       Impact factor: 9.473

Review 6.  How laboratory studies of cigarette craving can inform the experimental alcohol craving literature.

Authors:  Kasey G Creswell; Michael A Sayette
Journal:  Alcohol Clin Exp Res       Date:  2022-01-28       Impact factor: 3.928

Review 7.  Barriers and Breakthroughs in Targeting the Oxytocin System to Treat Alcohol Use Disorder.

Authors:  Andrey E Ryabinin; Yangmiao Zhang
Journal:  Front Psychiatry       Date:  2022-02-28       Impact factor: 4.157

8.  Oxytocin moderates corticolimbic social stress reactivity in cocaine use disorder and healthy controls.

Authors:  Jane E Joseph; Nicholas Bustos; Kathleen Crum; Julianne Flanagan; Nathaniel L Baker; Karen Hartwell; Megan Moran Santa-Maria; Kathleen Brady; Aimee McRae-Clark
Journal:  Compr Psychoneuroendocrinol       Date:  2022-06-12

9.  Elevated Oxytocin Receptor Blood Concentrations Predict Higher Risk for, More, and Earlier 24-Month Hospital Readmissions after In-Patient Detoxification in Males with Alcohol Use Disorder.

Authors:  Christiane Mühle; Massimiliano Mazza; Christian Weinland; Claudia von Zimmermann; Patrick Bach; Falk Kiefer; Valery Grinevich; Iulia Zoicas; Johannes Kornhuber; Bernd Lenz
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

Review 10.  Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review.

Authors:  Pascal Valentin Fischler; Michael Soyka; Erich Seifritz; Jochen Mutschler
Journal:  Front Pharmacol       Date:  2022-10-03       Impact factor: 5.988

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.